Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gossamer Bio (GOSS) Gross Profit: 2022-2025

Historic Gross Profit for Gossamer Bio (GOSS) over the last 4 years, with Sep 2025 value amounting to $13.3 million.

  • Gossamer Bio's Gross Profit rose 40.23% to $13.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.1 million, marking a year-over-year decrease of 79.74%. This contributed to the annual value of $90.7 million for FY2024, which is 771.30% up from last year.
  • Per Gossamer Bio's latest filing, its Gross Profit stood at $13.3 million for Q3 2025, which was up 15.71% from $11.5 million recorded in Q2 2025.
  • Gossamer Bio's Gross Profit's 5-year high stood at $95.8 million during Q2 2024, with a 5-year trough of -$14.6 million in Q4 2024.
  • In the last 3 years, Gossamer Bio's Gross Profit had a median value of -$3.1 million in 2024 and averaged $9.9 million.
  • Within the past 5 years, the most significant YoY rise in Gossamer Bio's Gross Profit was 2,895.04% (2024), while the steepest drop was 351.44% (2024).
  • Quarterly analysis of 4 years shows Gossamer Bio's Gross Profit stood at -$3.5 million in 2022, then rose by 6.31% to -$3.2 million in 2023, then crashed by 351.44% to -$14.6 million in 2024, then soared by 40.23% to $13.3 million in 2025.
  • Its Gross Profit was $13.3 million in Q3 2025, compared to $11.5 million in Q2 2025 and $9.9 million in Q1 2025.